Transforming Infection & Inflammation Care with Precision Nanomedicine
Pioneering next-generation therapies to combat infections, inflammation, and surgical complications — from Edmonton to the world.
VISION
Deliver innovative, site-specific therapies that improve patient outcomes, reduce systemic side effects, and lower the burden on healthcare systems.
At FeynMed Solutions, we are reimagining how localized infections and inflammatory conditions are treated. Based in Edmonton, Alberta, with an operational pilot facility, we harness the power of precisely engineered nanocrystalline silver to develop targeted therapeutics and medical devices that address some of healthcare’s most stubborn challenges.
OUR TECHNOLOGY
Nanocrystalline Silver
This platform technology is potentially useful for the treatment of:
_j.jpg)
Wounds & Burns
.jpg)
Abdominal Adhesions
.jpg)
Urinary Tract Infections (UTIs)
.jpg)
Pulmonary Diseases
.jpg)
Viral Ocular Infection
.jpg)
Antimicrobial Resistance
Nanocrystalline Silver
Our patented platform controls the atomic and structural properties of silver nanocrystals. Our goal is to achieve unparalleled antimicrobial and anti-inflammatory effects. Our intended outcome will have the following characteristics:
-
Triple-action: Potent bactericidal, antiviral, and anti-inflammatory activity.
-
Versatile: Tunable formulations for diverse tissues and delivery routes.
-
Scalable: Manufactured efficiently at our Edmonton cGMP facility for global distribution.
Wound & Burn Care
Our first product will target chronic and acute wounds, leveraging proven nanocrystalline silver technology. We are currently exploring licensing and/or distribution opportunities to bring this innovation to market.
Pulmonary Infections
Hospital-acquired viral and bacterial pneumonias, and infections in COPD patients, pose growing threats. We intend to develop an inhaled solution, delivering a therapeutic solution directly to the lungs.
Abdominal Adhesion Prevention
Nearly 95% of patients undergoing abdominal surgery develop adhesions, which can lead to chronic pain, bowel obstructions, and costly reoperations. We anticipate that nanosilver-derived solutions may help prevent adhesions.
Urinary Tract Infections (UTIs)
Recurrent and catheter-associated UTIs are a major quality-of-life and cost burden, particularly in long-term care. We are addressing applications of our technology to address UTIs.
Ocular Applications
Eye infections and inflammation can jeopardize vision and require intensive treatments, and there are currently no treatments available for viral conjunctivitis. Our technology has the potential to effectively treat a range of ophthalmological conditions.
Why FeynMed Solutions
FeynMed Solutions is built on a vision of transforming how localized infections and inflammatory conditions are treated
By focusing on both immediate market opportunities, like wound care, and large-scale unmet needs in surgical adhesion prevention, pulmonary infections, urinary tract infections, and ocular diseases, FeynMed is uniquely positioned to drive patient-centered innovation and deliver meaningful health and economic impact across Canada and around the world.
FeynMed Solutions In Numbers
200M+
POTENTIAL PATIENTS
9
CORE TEAM MEMBERS
6+
MEDICAL APPLICATIONS
